218 results about "Dose delivery" patented technology

A system for treating chronic inflammation may include an implantable microstimulator, a wearable charger, and optionally an external controller. The implantable microstimulator may be implemented as a leadless neurostimulator implantable in communication with a cervical region of a vagus nerve. The microstimulator can address several types of stimulation including regular dose delivery. The wearable charger may be worn around the subject's neck to rapidly (<10 minutes per week) charge an implanted microstimulator. The external controller may be configured as a prescription pad that controls the dosing and activity of the microstimulator.

A system for treating chronic inflammation may include an implantable microstimulator, a wearable charger, and optionally an external controller. The implantable microstimulator may be implemented as a leadless neurostimulator implantable in communication with a cervical region of a vagus nerve. The microstimulator can address several types of stimulation including regular dose delivery. The wearable charger may be worn around the subject's neck to rapidly (<10 minutes per week) charge an implanted microstimulator. The external controller may be configured as a prescription pad that controls the dosing and activity of the microstimulator.

A multiple pulsed dose drug delivery system for pharmaceutically active amphetamine salts, comprising a pharmaceutically active amphetamine salt covered with an immediate-release coating and a pharmaceutically active amphetamine salt covered with an enteric coating wherein the immediate release coating and the enteric coating provide for multiple pulsed dose delivery of the pharmaceutically active amphetamine salt. The product can be composed of either one or a number of beads in a dosage form, including either capsule, tablet, or sachet method for administering the beads.

A vaginal brachytherapy applicator is versatile to different anatomies and more comfortable to the patient than prior applicators. An inflatable balloon on a shaft may be inelastic or elastic. In one embodiment the shaft is rotatable relative to the balloon for enabling a ring or band of dose delivery, for versatility in radiation placement. Alternatively, the source can be rotated and pulled back within a stationary shaft. An adjustment is provided for reducing the length of balloon that inflates, to accommodate different anatomies and positions. Although isotope radiation sources can be used in the applicator, an electronic source is preferred, and the system and method include procedures for using the applicator with an electronic source.

A system for capture of dose delivery information is provided. The system includes a medication delivery device, a dose information capture device adapted to be attached to the medication delivery device, and a target element adapted to be attached to the medication delivery device. The target element comprises a magnet or ferrous element and the target element attaches to the medication delivery device on a dose delivery mechanism of the medication delivery device. The dose information capture device includes a magnetic position sensor adapted to detect a position of the target element. As an alternative to magnetic sensing, MEMS flow sensors, and the like may also be used. Exemplary systems preferably transmit dose information in real time to remote devices for further processing.

The inhalation therapy assembly and method of use described herein increases the efficiency of metered dose inhalers by allowing delivery of the doses to a collapsible reservoir which can be manually pumped, ensuring that medicants contained therein are properly and completely delivered to the patient. Terminal and proximal valves of the one-way diaphragm type allow flow of the aerosol medicants while preventing improper expulsion. An exhalation valve is adjustable to ensure the patient exhales suitably to permit proper medicant absorption. A conventional metered dosage inhaler having an approved FDA canister provides proper dosage to the patient and is joined to the collapsible reservoir by a connector having a plurality of apertures for receiving the MDI and an accessory T-fitting.

Embodiments of the disclosure include a transponder for determining a characteristic of a dose delivery device. The transponder may include a first sensor configured to detect a first parameter of the dose delivery device based on movement of at least one of the dose delivery device or a medicament contained within the dose delivery device, wherein the first sensor is configured to generate a first signal indicative of the first parameter. The transponder may include a processor operably coupled to the first sensor and configured to process the first signal. The transponder may include an indicator unit operably coupled to the processor and configured to generate an output based on the first signal, wherein the output is perceivable by a user. The transponder may also include a battery configured to provide power to at least one of the first sensor, the processor, and the indicator unit.

The inhalation therapy assembly and method of use described herein increases the efficiency of metered dose inhalers by allowing delivery of the doses to a collapsible reservoir which can be manually pumped, ensuring that medicants contained therein are properly and completely delivered to the patient. Terminal and proximal valves of the one-way diaphragm type allow flow of the aerosol medicants while preventing improper expulsion. An exhalation valve is adjustable to ensure the patient expires suitably to permit proper medicant absorption.

Convenience kits designed to provide for closed, but selectable liquid transfer from a vial to a variety of IV containers and medical syringes. In particular, a kit for fully enclosing a vial for safety in hazardous drug transfer is disclosed. Generally, the kits contain unitized parts wherever reasonable to limit makes and breaks. Further, pathway determining kits provide selectable pathways for purging connections wish flushing solution where makes and breaks are made between various fluid pathway involved parts such that, when disconnections are made, flush solution is resident at the exposed interface. Also disclosed is a 3-way valve as part of a closed, switchable pathway controlling subsystem by which pathways are selected for reconstituting dry medicine in a vial, displacing a measured dose of liquid from a vial, exchanging gas into the vial for displaced liquid, delivering the measured dose to an IV container.

A system for capture of dose delivery information is provided. The system includes a medication delivery device, a dose information capture device adapted to he attached to the medication delivery device, and a target element adapted to be attached to the medication delivery device. The target element comprises a magnet or ferrous element and the target element attaches to the medication delivery device on a dose delivery mechanism of the medication delivery device. The dose information capture device includes a magnetic position sensor adapted to detect a position of the target element. As an alternative to magnetic sensing, MEMS flow sensors, and the like may also be used. Exemplary systems preferably transmit dose information in real time to remote devices for further processing,

The present invention encompasses a solid dose delivery vehicle for ballistic administration of a bioactive material to subcutaneous and intradermal tissue, the delivery vehicle being sized and shaped for penetrating the epidermis. The delivery vehicle further comprises a stabilizing polyol glass loaded with the bioactive material and capable of releasing the bioactive material in situ. The present invention further includes methods of making and using the solid dose delivery vehicle of the invention.

A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module (4) containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle (3). The medicated module (4) is user selectable so that it will deliver a priming dose of a primary medicament or both the primary and secondary medicaments. The module (4) also contains a needle guard (42) that locks after dose delivery. The needle guard (42) prevents accidental needle sticks before and after an injection. A locking collar (66) rotates during use as an inner protrusion (12) follows three paths (14, 15, 16) of a track (13) located on the outer surface of a body housing (10). When the inner facing protrusion (12) is in the third path (16), it encounters a hard stop and a rotational bias that locks the guard (42) from further retraction and thus covers the sharp distal end of the needle (3).

The present invention encompasses a solid dose delivery vehicle for ballistic administration of a bioactive material to subcutaneous and intradermal tissue, the delivery vehicle being sized and shaped for penetrating the epidermis. The delivery vehicle further comprises a stabilizing polyol glass loaded with the bioactive material and capable of releasing the bioactive material in situ. The present invention further includes methods of making and using the solid dose delivery vehicle of the invention.

The invention relates to improved methods and systems for computationally efficient optimization of radiation dose delivery. The optimization involves determining an improved form of objective function to be used for mapping radiotherapy beams to a patient body volume having at least one target volume and at least one non-target volume. The objective function has a first term related to the at least one target volume and a second term related to the at least one non-target volume. The optimization further involves determining a minimum of the objective function, whereby beams mapped so as to pass through the at least one non-target volume are limited such that the second term is zero only if the weights of beamlets passing through the at least one non-target volume are zero. This limit helps to avoid the occurrence of negative beam weights, thereby facilitating computationally efficient determination of the minimum of the objective function using matrix inversion. Following the optimization, radiotherapy is delivered based on the determined minimum of the objective function.

A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module (4) containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle (3). The medicated module (4) does not require the user to manually engage a reservoir (22) containing the secondary medicament. Instead, a biasing member (48) automatically activates the reservoir (22) when the needle guard (42) is retracted. The needle guard (42) prevents accidental needle sticks before and after an injection, and locks after dose delivery.

A dose counter device for an inhaler registers when a dose is delivered. The dose counter is adapted to mount on the distal end of the inhaler. The inhaler includes a canister comprising an inhaler housing. The dose counter device comprises a device trigger provided in an electron circuit on the distal end of the canister. The electron circuit further comprises an acoustic sensor also provided on the distal end of the canister. A force sensor is adapted to activate the acoustic sensor when a force is applied to the distal end of the canister. The acoustic sensor registers dose delivery when it picks up a sound.

Improved systems and methods for medicine delivery, and in particular, improved insulin pen needles and related devices are provided. Smart injection devices record and transfer data including medicine level, delivered dose, dose confirmation, and dose time and date. Additional data captured may include glucose concentration, insulin level, carbohydrates ingested, stress level, exercise, blood pressure, and glucose high and low excursion events. Various means of data collection and analysis are provided and systems can identify and flag patients who require intervention. Smart sleeves and add sensing capability to standard insulin pens. Pen needles are provided with sensing capability to confirm and measure doses delivered by insulin pen. A two-part pen cap include a primary sleeve that connects to the insulin pen and an end cap that provides for capturing the time of dose delivery, and monitoring the hold time for a dose delivery after plunger movement.

A dose delivery device is disclosed where a dose can be set by rotating a dose setting member, whereby a push button is elevated from one end of the device a distance proportional to the set dose from a position fixed relative to the housing, and where the set dose can then be injected by pressing the push button back to its non-elevated position, through which motion a piston rod will move the same or a different distance due to a gearing mechanism being provided between the push button and the piston rod, where the gearing mechanism includes at least a first and a second thread on one or more parts that are rotationally coupled to each other, the first thread engaging a driver, the second thread engaging an element rotationally locked to the driver, one of the threads of the gearing mechanism being left-handed and the other one being right-handed.

The invention relates to methods and systems for computationally efficient optimization of radiation dose delivery that involve determining an objective function to be used for mapping radiotherapy beams to a patient body volume having at least one target volume and at least one non-target volume. The objective function has a first term related to the at least one target volume and a second term related to the at least one non-target volume. The second term is zero only if the weights of beamlets mapped so as to pass through the non-target volume(s) are zero. The second term helps to avoid the occurrence of negative beam weights, thereby facilitating computationally efficient optimization using matrix inversion. An optimal set of weights of beamlets is determined using the objective function. Radiotherapy is delivered based on the determined optimal set of weights.

A multiple pulsed dose drug delivery system for pharmaceutically active amphetamine salts, comprising a pharmaceutically active amphetamine salt covered with an immediate-release coating and a pharmaceutically active amphetamine salt covered with an enteric coating wherein the immediate release coating and the enteric coating provide for multiple pulsed dose delivery of the pharmaceutically active amphetamine salt. The product can be composed of either one or a number of beads in a dosage form, including either capsule, tablet, or sachet method for administering the beads.

A vaginal brachytherapy applicator is versatile to different anatomies and more comfortable to the patient than prior applicators. An inflatable balloon on a shaft may be inelastic or elastic. In one embodiment the shaft is rotatable relative to the balloon for enabling a ring or band of dose delivery, for versatility in radiation placement. Alternatively, the source can be rotated and pulled back within a stationary shaft. An adjustment is provided for reducing the length of balloon that inflates, to accommodate different anatomies and positions. Although isotope radiation sources can be used in the applicator, an electronic source is preferred, and the system and method include procedures for using the applicator with an electronic source.

A supplemental device (2) for attachment to an injection device (1) comprises: a display (21); a processor arrangement (24); a dose dialed detector (25) operable to detect a dose of medicament dialed into an attached injection device (1); a dose delivery determiner (27) for determining that a dose of medicament has been delivered (24, 25); a quantity determiner determining a quantity of medicament that has been delivered; and a clock configured to determine a current time. The processor arrangement (24) is configured when the supplemental device is in a default mode to display both a quantity of medicament that was delivered since a last dose and a time elapsed since delivery of the last dose.

A dose counter device for an inhaler registers when a dose is delivered. The dose counter is adapted to mount on the distal end of the inhaler. The inhaler includes a canister comprising an inhaler housing. The dose counter device comprises a device trigger provided in an electron circuit on the distal end of the canister. The electron circuit further comprises an acoustic sensor also provided on the distal end of the canister. A force sensor is adapted to activate the acoustic sensor when a force is applied to the distal end of the canister. The acoustic sensor registers dose delivery when it picks up a sound.

A delivery device for the delivery of an agent to the mouth, nose or other bodily site of a user. The delivery device includes an aerosol canister that is actuated to expel propellant, which captures and disperses the agent. In a preferred embodiment, the propellant captures and disperses the agent into the mouth or nose of a user, and inhalation by the user directs the agent to the lungs of the user. The delivery device is particularly suitable for the treatment of bronchial asthma, respiratory conditions and for the delivery of systemically absorbed agents.

An adapter for achieving intradermal dosed delivery of a liquid by use of a dosed drug delivery device including a reservoir having a pierceable septum, the adapter having a connector including an attachment configuration for attachment to the dosed drug delivery device and a hollow needle deployed for piercing the septum. A liquid delivery interface, linked to the connector, includes a straight skin contact edge and one or more hollow microneedle adjacent thereto. The microneedle projects away from the skin contact edge. A flow path arrangement interconnects the needle and the at least one hollow microneedle.

A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device (7) containing a primary medicament accepts a medicated module (4) containing a single dose of a secondary medicament and where both medicaments are delivered through a single hollow needle (3). The medicated module (4) is configured so that it will first deliver both the primary and secondary medicaments and then, if needed, a dose(s) of additional primary medicament. The module (4) also contains a needle guard (22) that locks the first dose delivery, but can be manually overridden by a user to perform a second or subsequent injection of primary medicament.

A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle (3). The medicated module does not require the user to manually engage a reservoir (22) containing the secondary medicament. Instead, a biasing member (48) automatically activates the reservoir when the needle guard (42) is retracted. The needle guard prevents accidental needle sticks before and after an injection, and locks after dose delivery.

A drug delivery device (1; 100; 200) comprising a housing (2; 102; 201, 202), a dose setting mechanism operable to set a dose to be delivered from a variable volume reservoir, and a dose delivery structure (60; 160; 260) activatable to expel a set dose. The dose setting mechanism comprises a dose indicating structure (40; 140; 240) for indicating a size of the set dose. The dose indicating structure (40; 140; 240) is coupled with the dose delivery structure (60; 160; 260) during expelling of the set dose and moved relative to the housing (2; 102; 201, 202) to a zero dose indicating position. The zero dose indicating position is a position which is fixed with respect to the housing (2; 102; 201, 202). The dose setting mechanism further comprises a dose setting structure (20; 120; 220) movable in a dose preparing direction relative to the housing (2; 102; 201, 202) to a dose prepared position to set a dose of a first size. The dose prepared position is a position along the dose preparing direction which is fixed with respect to the housing (2; 102; 201, 202). The dose setting structure (20; 120; 220) and the dose indicating structure (40; 140; 240) are coupled and configured to undergo first correlated displacements relative to the housing (2; 102; 201, 202) during movement of the dose indicating structure (40; 140; 240) to the zero dose indicating position and further coupled and configured to undergo second correlated displacements relative to the housing (2; 102; 201, 202) during movement of the dose setting structure (20; 20; 220) to the dose prepared position, where the first correlated displacements and the second correlated displacements are mutually reverse. Further, when the dose setting structure (20; 120; 220) is in the dose prepared position the dose indicating structure (40; 140; 240) is selectively displaceable relative to the housing (2; 102; 201, 202) while the dose setting structure (20; 120; 220) remains stationary in the dose preparing direction to allow adjustment of the dose of the first size and thereby setting of a dose of a second size.

A container includes, in one embodiment, an outer housing holding a first mass of a first component of a composition, an inner housing holding a second mass of a second component of the composition, and a seal. The first component is a liquid and the mass of the second component conforms to a bottom and side wall of the inner housing. An interference fit exists between the outer housing and the inner housing such that the inner housing seals the first mass within the first chamber. The inner housing has an aperture in a side wall of the second chamber.